Glucosylceramides trigger the shedding of alpha-synuclein laden ectosomes

References

[1] McCann H,Cartwright H,Halliday GM. Neuropathology of α-synuclein propagation and braak hypothesis Mov Disord 2016 31 152 60

[2] Braak H,Del Tredici K,Rüb U,de Vos RA,Jansen Steur EN,Braak E. Staging of brain pathology related to sporadic Parkinson’s disease Neurobiol Aging 2003 24 197 211

[3] Rey NL,Steiner JA,Maroof N.et al. Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease J Exp Med 2016 213 1759 78 PMC4995088

[4] Van Den Berge N,Ferreira N,Gram H.et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats Acta Neuropathol 2019 138 535 50 PMC6778265

[5] Ferreira N,Gonçalves NP,Jan A.et al. Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain Acta Neuropathol Commun 2021 9 31 PMC7905893

[6] Andersen KB,Krishnamurthy A,Just MK.et al. Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals Nat Neurosci 2025 28 925 36 PMC12081295

[7] Bernis ME,Babila JT,Breid S,Wüsten KA,Wüllner U,Tamgüney G. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein Acta Neuropathol Commun 2015 3 75 PMC4660655

[8] Tardivel M,Bégard S,Bousset L.et al. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies Acta Neuropathol Commun 2016 4 117 PMC5096005

[9] Rostami J,Holmqvist S,Lindström V.et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes J Neurosci 2017 37 11835 53 PMC5719970

[10] Abounit S,Bousset L,Loria F.et al. Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes EMBO J 2016 35 2120 38 PMC5048354

[11] Chakraborty R,Nonaka T,Hasegawa M,Zurzolo C. Tunnelling nanotubes between neuronal and microglial cells allow bi-directional transfer of α-Synuclein and mitochondria Cell Death Dis 2023 14 329 PMC10195781

[12] Scheiblich H,Dansokho C,Mercan D.et al. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes Cell 2021 184 5089 106.e21 PMC8527836

[13] Scheiblich H,Eikens F,Wischhof L.et al. Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes Neuron 2024 112 3106 25.e8

[14] Danzer KM,Kranich LR,Ruf WP.et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers Mol Neurodegener 2012 7 42 PMC3483256

[15] Kurzawa-Akanbi M,Tammireddy S,Fabrik I.et al. Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders Acta Neuropathol 2021 142 961 84 PMC8568874

[16] Ishiguro Y,Tsunemi T,Shimada T.et al. Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson’s pathology Biochem Biophys Res Commun 2024 703 149620

[17] Du TT,Wang L,Duan CL.et al. GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A Autophagy 2015 11 1803 20 PMC4824589

[18] Muñoz SS,Petersen D,Marlet FR,Kücükköse E,Galvagnion C. The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson’s disease Biophys Chem 2021 273 106534

[19] Murphy KE,Gysbers AM,Abbott SK.et al. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease Brain 2014 137 834 48 PMC3927701

[20] Mazzulli JR,Xu YH,Sun Y.et al. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies Cell 2011 146 37 52 PMC3132082

[21] Zunke F,Moise AC,Belur NR.et al. Reversible conformational conversion of α-synuclein into toxic assemblies by glucosylceramide Neuron 2018 97 92 107.e10 PMC6013314

[22] Taguchi YV,Liu J,Ruan J.et al. Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson’s disease J Neurosci 2017 37 9617 31 PMC5628407

[23] Franck L,Hahnefeld L,Valek L.et al. Elevated hexosylceramides in Parkinson’s disease cause gene upregulations in neurons mimicking responses to pathogens NPJ Parkinsons Dis 2025 11 268 PMC12398573

[24] Wang R,Sun H,Cao Y.et al. Glucosylceramide accumulation in microglia triggers STING-dependent neuroinflammation and neurodegeneration in mice Sci Signal 2024 17 eadk8249

[25] Jacquemyn J,Marriott B,Chang J.et al. Glucosylceramide-induced ectosomes propagate pathogenic α-synuclein in Parkinson’s disease Nat Cell Biol 2026 28 492 506

[26] Brodeur A,Migneault F,Lanoie M.et al. Apoptotic exosome-like vesicles transfer specific and functional mRNAs to endothelial cells by phosphatidylserine-dependent macropinocytosis Cell Death Dis 2023 14 449 PMC10359336

[27] Zhang C,Yang Z,Zhou P.et al. Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer Theranostics 2021 11 6445 60 PMC8120203

[28] Wei X,Liu C,Wang H.et al. Surface phosphatidylserine is responsible for the internalization on microvesicles derived from hypoxia-induced human bone marrow mesenchymal stem cells into human endothelial cells PLoS One 2016 11 e0147360 PMC4726621

[29] Abdulsahib WK,Mustafa WW,Jyothi SR.et al. Unveiling exosomes and microvesicles in Parkinson’s disease: mechanistic insights into cell death pathways and therapeutic potential Mol Neurobiol 2025 63 187

[30] Cable J,Witwer KW,Coffey RJ.et al. Exosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia report Ann N Y Acad Sci 2023 1523 24 37 PMC10715677

[31] Alvarez-Erviti L,Seow Y,Schapira AH.et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission Neurobiol Dis 2011 42 360 7 PMC3107939

[32] Shi M,Liu C,Cook TJ.et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease Acta Neuropathol 2014 128 639 50 PMC4201967

[33] Emmanouilidou E,Vekrellis K. Exocytosis and spreading of normal and aberrant α-synuclein Brain Pathol 2016 26 398 403 PMC8029167

[34] Papadopoulos VE,Nikolopoulou G,Antoniadou I.et al. Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson’s disease Hum Mol Genet 2018 27 1696 710

[35] Jiang C,Hopfner F,Berg D.et al. Validation of α-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of Parkinsonian syndromes Mov Disord 2021 36 2663 9 PMC8663480

[36] Jiang C,Hopfner F,Katsikoudi A.et al. Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism J Neurol Neurosurg Psychiatry 2020 91 720 9 PMC7361010

[37] Niu M,Li Y,Li G.et al. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression Eur J Neurol 2020 27 967 74

[38] Mahapatra A,Malingen SA,Rangamani P. Interplay between cortical adhesion and membrane bending regulates the formation of microparticles Soft Matter 2026 22 1569 82

[39] Sun M,Xue X,Li L.et al. Ectosome biogenesis and release processes observed by using live-cell dynamic imaging in mammalian glial cells Quant Imaging Med Surg 2021 11 4604 16 PMC8511719

[40] Bayati A,Banks E,Han C.et al. Rapid macropinocytic transfer of α-synuclein to lysosomes Cell Rep 2022 40 111102

[41] Park JY,Kim KS,Lee SB.et al. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft J Neurochem 2009 110 400 11

[42] Lai RC,Lim SK. Membrane lipids define small extracellular vesicle subtypes secreted by mesenchymal stromal cells J Lipid Res 2019 60 318 22 PMC6358289

[43] Matsumura S,Minamisawa T,Suga K.et al. Subtypes of tumour cell-derived small extracellular vesicles having differently externalized phosphatidylserine J Extracell Vesicles 2019 8 1579541 PMC6394288

[44] Skotland T,Llorente A,Sandvig K. Lipids in extracellular vesicles: what can be learned about membrane structure and function? Cold Spring Harb Perspect Biol 2023;15:a041415 PMC10411865

[45] Xie YX,Naseri NN,Fels J.et al. Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models Nat Commun 2022 13 4918 PMC9395532

[46] Tsunemi T,Perez-Rosello T,Ishiguro Y.et al. Increased lysosomal exocytosis induced by lysosomal Ca²⁺ channel agonists protects human dopaminergic neurons from α-synuclein toxicity J Neurosci 2019 39 5760 72 PMC6636071

[47] Dutta S,Hornung S,Kruayatidee A.et al. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy Acta Neuropathol 2021 142 495 511 PMC8357708

[48] Ohmichi T,Mitsuhashi M,Tatebe H,Kasai T,Ali El-Agnaf OM,Tokuda T. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson’s and related diseases Parkinsonism Relat Disord 2019 61 82 7

[49] Sepúlveda D,Cisternas-Olmedo M,Arcos J,Nassif M,Vidal RL. Contribution of autophagy-lysosomal pathway in the exosomal secretion of alpha-synuclein and its impact in the progression of Parkinson’s disease Front Mol Neurosci 2022 15 805087 PMC8891570

[50] Magalhaes J,Gegg ME,Migdalska-Richards A,Schapira AH. Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons Sci Rep 2018 8 1385 PMC5780491

[51] Fois G,Hobi N,Felder E.et al. A new role for an old drug: ambroxol triggers lysosomal exocytosis via pH-dependent Ca²⁺ release from acidic Ca²⁺ stores Cell Calcium 2015 58 628 37

[52] Franck L,Valek L,Hahnefeld L.et al. Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1^-/-SNCA^A53T double mutant mouse model of Parkinson’s disease Acta Pharmacol Sin 2026 47 836 59 PMC13018195

[53] Wu KM,Xu QH,Liu YQ.et al. Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease Science 2025 387 892 900

[54] Mao X,Ou MT,Karuppagounder SS.et al. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3 Science 2016 353 aah3374 PMC5510615

[55] Zhang Q,Duan Q,Gao Y.et al. Cerebral microvascular injury induced by lag3-dependent α-synuclein fibril endocytosis exacerbates cognitive impairment in a mouse model of α-synucleinopathies Adv Sci 2023 10 e2301903 PMC10477873

[56] Ambrosi G,Ghezzi C,Zangaglia R,Levandis G,Pacchetti C,Blandini F. Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson’s disease cells Neurobiol Dis 2015 82 235 42

[57] Colucci F,Avenali M,De Micco R.et al. Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol BMJ Neurol Open 2023 5 e000535 PMC10679992

[58] Stuendl A,Kunadt M,Kruse N.et al. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies Brain 2016 139 481 94 PMC4805087

[59] Ugalde CL,Gordon SE,Shambrook M.et al. An intact membrane is essential for small extracellular vesicle-induced modulation of α-synuclein fibrillization J Extracell Vesicles 2020 10 e12034 PMC7726797

[60] Ulmer TS,Bax A,Cole NB,Nussbaum RL. Structure and dynamics of micelle-bound human alpha-synuclein J Biol Chem 2005 280 9595 603

[61] Tuttle MD,Comellas G,Nieuwkoop AJ.et al. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein Nat Struct Mol Biol 2016 23 409 15 PMC5034296